| answer text |
<p>Science-based evidence is at the heart of our policy making in Defra. Zoonotic
infections threaten both human and animal health and we have systems in place to detect
and manage outbreaks, for both endemic (those that are already found in the UK) and
exotic infections. We collaborate closely with the public health agencies, as outlined
in our contingency plan on how we would work with other Government agencies and departments
to control zoonotic diseases as well as those only affecting livestock. This is being
put to use at the moment, through our response to avian influenza outbreaks. These
plans rely heavily on the most up-to-date evidence base, whether considering new diagnostic
technology, delivery of control measures, surveillance, tracing or prevention with
vaccination.</p><p>To this end, we have allocated £200 million to the Animal and Plant
Health Agency science campus at Weybridge. This substantial investment recognises
the essential role of this Government capability, as the first stage of a long-term
programme of work to safeguard and enhance facilities. This will enable its world-leading
scientists to continue at the forefront of research and policy to protect people,
the environment and the economy, by boosting our resilience and strengthening our
understanding of health risks to, and from, animals and plants.</p><p>In addition,
in the latest Spending Review, Defra received an uplift to their capital DEL for evidence
R&D to support science programme spend for three years. This includes programmes
for endemic and exotic diseases, for new emerging diseases and for zoonotic disease
programmes.</p><p> </p>
|
|
